ANAPTYSBIO, INC.— Sankey Diagram
Annual mode · period ending 2025-12-31 · SEC EDGAR
FY2025 - Q4(Oct 25 · Nov 25 · Dec 25)
Total Assets
$364M
↓-24.7% -$119Mvs FY2024
Total Liabilities
$39M
↓-15.0% -$7Mvs FY2024
Equity
$37M
↓-47.5% -$34Mvs FY2024
Cash
$238M
↑+93.5% +$115Mvs FY2024
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $364M | $484M |
| Current Assets | $350M | $432M |
| Cash | $238M | $123M |
| ST Investments | $0 | $0 |
| Receivables | $0 | $0 |
| Inventory | $0 | $0 |
| Other Current | $112M | $309M |
| Non-Current Assets | $14M | $52M |
| PPE | $1M | $2M |
| Goodwill | $0 | $0 |
| Intangibles | $0 | $0 |
| Investments | $0 | $0 |
| Other Non-Current | $13M | $50M |
| Total Liab+Eq | $37M | $71M |
| Current Liab. | $39M | $45M |
| Accounts Payable | $4M | $4M |
| Short-Term Debt | $0 | $0 |
| Deferred Revenue | $0 | $0 |
| Other CL | $35M | $41M |
| Non-Current Liab. | $0 | $0 |
| Long-Term Debt | $0 | $0 |
| Other LT Liab. | $0 | $0 |
| Equity | $37M | $71M |
| Retained Earnings | $773M | $759M |
| Other Equity | $0 | $0 |
QuarterCharts · SEC EDGAR data · ANAB · Comparing FY2025 vs FY2024